Intrauterine insemination is a type of fertility treatment, performed with an objective to increase number of sperms entering a woman’s uterus, so as to increase chances of getting pregnant. The intrauterine insemination is a type of minimally invasive technique and is mostly preferred to other fertilization procedures in most developed economies.
High prevalence of infertility across developed and developing economies coupled with growing awareness about fertilization treatments are major factors boosting growth of the global intrauterine insemination (IUI) treatment market. Additionally, growing adoption of intrauterine insemination (IUI) treatments in developing economies and minimal invasive nature of the treatment are other major factors propelling growth of the global market over the forecast period. But, availability of substitute treatments and problems associated with intrauterine insemination (IUI) treatment are major factors hampering growth of the global market.
The global intrauterine insemination (IUI) treatment market report has been segmented on the basis of end users, and region. On the basis of region, the global intrauterine insemination (IUI) treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Request for the Sample Report Here: https://marketresearch.biz/report/intrauterine-insemination-iui-treatment-market/request-sample/
The market in North America accounted for highest share in terms of revenue in the global market, and is projected to maintain its dominance over the forecast period. This can be attributed to high prevalence of infertility coupled with presence of proper healthcare facilities in the region. Revenue from the market in Europe accounted for second-highest revenue share in the global intrauterine insemination (IUI) treatment market, and is closely followed by markets in Asia Pacific, Latin America, and Middle East & Africa respectively. Moreover, revenue from the market in Asia Pacific is projected to witness significant growth over the forecast period, and is expected to register a CAGR of X.X%. Lifestyle changes, increasing incidence of infertility, and rising adoption of fertilization treatments in emerging economies are major factors for the market in Asia Pacific to witness significant growth. Furthermore, the market in Latin America is projected to witness moderate growth over the forecast period.
Prominent players in the global intrauterine insemination (IUI) treatment market include Labotect GmbH, Fernandez Hospital, Apollo Fertility, Sunflower Hospital, Brigham and Women’s Hospital, BMI Healthcare, University Hospitals Coventry and Warwickshire, Conceive Hospital, London Women’s Clinics.